Cepheid
David Persing is an accomplished executive in the medical and technology fields, currently serving as Executive Vice President and Chief Medical and Technology Officer at Cepheid since August 2005, where responsibilities include directing global research and development, establishing new initiatives, and engaging with the clinical community. Prior to this role, David worked at Corixa as Chief Scientific Officer and Vice President of Discovery Research, focusing on vaccine research and innate immunity. David's foundational experience includes founding and directing the Molecular Microbiology Laboratory at Mayo Clinic and completing a residency in Laboratory Medicine at Yale University School of Medicine. David holds MD and PhD degrees from the University of California, San Francisco, and a BA in Chemistry from San Jose State University.
This person is not in any teams
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.